Fermer le menu


Member of Lyonbiopole


VERSEVRAGE is a startup dedicated to a topical subject of major public health interest in France and internationally, smoking cessation.

We are developing an innovative treatment through our NICØDIØL solution. It is the association of an electronic drug delivery system (EDDS) by vaporization, considered as a medical device, with patented liquid formulations combining nicotine and cannabidiol (CBD) considered as the medicine. The objective is to become the first electronic tobacco and nicotine substitute in the world to obtain marketing authorization and to be considered like other nicotine replacement treatments (patch, gum).

This project represents an enrichment of the therapeutic arsenal around smoking cessation and more broadly a new road of drug administration in the future.


Application market: Pneumology - Respiratory Diseases, Public Health & Patient care

Type of activity: Medical device, Therapeutics, Pharma or Biotech

Technologies: Drug delivery device & Technologies

Created on feb. 8th, 2021 - 3 employees



6 allée Jean Orcel 38120 Fontanil Cornillon



Vous devez être connecté et membre de Lyonbiopôle pour voir les contacts.